peginesatide acetate

peginesatide acetate (OMONTYS) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda. Route of administration: intravenous, subcutaneous. Current US regulatory status: approved.

OMONTYS is a marketed brand name for peginesatide acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

peginesatide acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.